Hair · Female Hair Loss · FPHL
FPHL causes gradual crown and midpart thinning — halted and significantly improved with the right combination of medical treatment and in-clinic procedures.
About This Treatment
Female Pattern Hair Loss (FPHL) is diffuse thinning at the crown and widening of the central parting, with the frontal hairline typically preserved. Driven by genetic predisposition and hormonal factors including PCOS and post-menopausal oestrogen decline. Medical treatment (topical minoxidil, hormonal management) combined with monthly GFC/PRP/Exosome sessions halts progression and restores density. Hair transplant for advanced stable cases with adequate donor hair.
How It Works
FAQs
Genetic predisposition, hormonal changes (PCOS, menopause), iron deficiency, thyroid disorder, and significant stress.
Untreated, FPHL progresses over time. With appropriate treatment, progression is halted and density significantly improves — especially when started early.
Treatment significantly improves density and reduces shedding — especially with early intervention and GFC/Exosome therapy. Complete reversal of advanced miniaturisation is limited.
Yes — topical 5% and low-dose oral minoxidil are safe and effective for FPHL. Dr. Megha prescribes the appropriate formulation.
Yes — selected women with stable FPHL and adequate donor hair are excellent hair transplant candidates.
Free Consultation
Dr. Megha Sharma personally assesses every patient. Our team responds within 30 minutes.